Sign up to get Today’s Best Articles in your inbox
Join 350,000+ subscribers and keep yourself informed with a selection of
The Week’s most interesting, enlightening and entertaining stories - plus daily puzzles.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
An account already exists for this email address, please log in.
Radical MS treatment can halt disease – but could be fatal
Patients face heart-breaking dilemma over treatment that leaves immune system dangerously vulnerable
A radical treatment for multiple sclerosis has given a number of trial volunteers their lives back - but it comes with a deadly dilemma.
MS causes the immune system to attack the protective layer around nerve fibres in the spinal cord, optic nerves and brain, which can leave patients paralysed and blind.
Using a procedure more commonly used to treat leukaemia, the new therapy "erases" the patient's immune system via chemotherapy and then "reboots" it with a transfusion of stem cells previously collected from the patient and purified.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Join more than 350,000 subscribers and keep yourself informed with a selection of The Week’s most interesting, enlightening and entertaining stories - plus daily puzzles.
Join more than 350,000 subscribers and keep yourself informed with a selection of The Week’s most interesting, enlightening and entertaining stories - plus daily puzzles.
However, the treatment comes with astounding risks and leaves the patients dangerously vulnerable until the stem cells take effect. One of the 24 volunteers in the latest medical trial died after developing a liver infection.
On the other hand, the potential benefits are equally astounding. Although the treatment only aims to halt the progress of the disease, some patients reported a life-changing improvement in their condition.
Follow-up reports on the 24 patients in the trial, carried out at the Ottawa Hospital, revealed that MS symptoms had halted in 70 per cent of patients and 40 per cent went into remission.
Canadian Jennifer Molson told New Scientist that when she had needed a wheelchair when she volunteered.
Sign up to get Today’s Best Articles in your inbox
A free daily email with the day’s biggest news and analysis – and the best features from TheWeek.com
"I took a leap of faith. I felt like I would be kicking myself if I didn't take this chance," she said. After 18 months, her symptoms began to disappear and now she can walk, work full-time and enjoy skiing holidays with her husband.
"This is very exciting," Dr Harold Atkins told the Daily Telegraph. He cautioned that the therapy had "serious side effects and risks" and was only appropriate for a small proportion of MS patients.
